Stock Market News & Analysis

stocks
Beaten down real estate share receives legal blow
Real estate share remains cheap despite losing airport legal battle.
Beaten down real estate share receives legal blow
Beaten down real estate share receives legal blow
stocks
OpenAI joins the mega-AI lab IPO race, but timing is uncertain

OpenAI joins the mega-AI lab IPO race, but timing is uncertain

The ChatGPT maker joined Anthropic in filing a confidential S-1 with the SEC, teeing up a future IPO.
stocks
What happens if Tesla and SpaceX merge?

What happens if Tesla and SpaceX merge?

We see a solid business case for a merger, but not without hurdles, including Tesla shareholders’ concern about SpaceX’s valuation.
stocks
The 5 best US dividend aristocrats to watch in 2026

The 5 best US dividend aristocrats to watch in 2026

How to avoid the dividend aristocrat trap.
stocks
Chart of the Week: Is CSL finally turning the ship around?

Chart of the Week: Is CSL finally turning the ship around?

The beaten down healthcare giant remains cheap on turnaround potential.
stocks
ASX top pick remains cheap with narrowing brand focus

ASX top pick remains cheap with narrowing brand focus

Shares remain cheap for ASX winemaker as the company narrows focus on high margin brands.
stocks
What did Morningstar subscribers buy and sell during May?

What did Morningstar subscribers buy and sell during May?

How the most traded shares in May stack up against our analysts views.
stocks
Avoid this overvalued ASX healthcare share

Avoid this overvalued ASX healthcare share

Expensive healthcare share limited by its core addressable market.
stocks
AI driving growth for ASX tech share

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks
OpenAI is going public as the worst value among its peers

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks
Wide moat healthcare leader remains undervalued

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.
stocks
This US AI winner has been unstoppable. Is it time to sell?

This US AI winner has been unstoppable. Is it time to sell?

Astonishing results have driven this AI stock into significantly overvalued territory.
stocks
ASX real estate share receives sharp downgrade

ASX real estate share receives sharp downgrade

The ASX property developer recieves sharp downgrade as asset sales disapoint.
stocks
ASX gold miner under pressure to sell by activist investor

ASX gold miner under pressure to sell by activist investor

Activist investor presses gold miner on selling to larger players.
stocks
Ask the Analyst: Will Amcor lose its dividend aristocrat status?

Ask the Analyst: Will Amcor lose its dividend aristocrat status?

When consistency becomes constraint.
stocks
Chart of the Week: We see opportunity in this beaten down industrial player

Chart of the Week: We see opportunity in this beaten down industrial player

The market sees risks and are discounting the shares excessively.
of 268
Viewing 1 to 16 of 4278